A randomized phase II study of OGX-427 plus prednisone versus prednisone alone in patients with chemotherapy-naive metastatic castration-resistant prostate cancer. Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Chi, Kim N
  • Hotte, Sebastien
  • Ellard, Susan
  • Gingerich, Joel Roger
  • Joshua, Anthony Michael
  • Kollmannsberger, Christian K
  • Yu, Evan Y
  • Gleave, Martin Edwin

publication date

  • February 10, 2012